Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations

Bart, Thomas; Boo, Michael; Balabanova, Snejana; Fischer, Yvonne; Nicoloso, Grazia; Foeken, Lydia; Oudshoorn, Machteld; Passweg, Jakob; Tichelli, Andre; Kindler, Vincent Lucien; Kurtzberg, Joanne; Price, Thomas; Regan, Donna; Shpall, Elizabeth J; Schwabe, Rudolf

doi:10.1159/000345690

Scientific article

English

Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations

ContributorsBart, Thomas; Boo, Michael; Balabanova, Snejana; Fischer, Yvonne; Nicoloso, Grazia; Foeken, Lydia; Oudshoorn, Machteld; Passweg, Jakob; Tichelli, Andre; Kindler, Vincent Lucien; Kurtzberg, Joanne; Price, Thomas; Regan, Donna; Shpall, Elizabeth J; Schwabe, Rudolf

Published inTransfusion medicine and hemotherapy, vol. 40, no. 1, p. 14-20

Publication date2013

Abstract

Over the last 2 decades, cord blood (CB) has become an important source of blood stem cells. Clinical experience has shown that CB is a viable source for blood stem cells in the field of unrelated hematopoietic blood stem cell transplantation.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Immunité innée non leucocytaire (928)

Citation (ISO format)

BART, Thomas et al. Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations. In: Transfusion medicine and hemotherapy, 2013, vol. 40, n° 1, p. 14–20. doi: 10.1159/000345690

Article (Published version)

Identifiers

PID : unige:43436
DOI : 10.1159/000345690
PMID : 23637645

Journal ISSN1660-3796

663views

529downloads

Creation15/12/2014 17:01:00

First validation15/12/2014 17:01:00

Update14/03/2023 22:27:20

Status update14/03/2023 22:27:19

Last indexation30/10/2024 21:28:14

Archive ouverte UNIGE

Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations

Over the last 2 decades, cord blood (CB) has become an important source of blood stem cells. Clinical experience has shown that CB is a viable source for blood stem cells in the field of unrelated hematopoietic blood stem cell transplantation.

Technical informations